维普中文期刊产品整合服务
14篇 您的检索式:作者名="Manikhas G"
    题名 作者 年代 出处 被引量
1Comparable activity with oral topotecan/cisolatin (TC) and etoposide/cisoatin (PE) as treatment for chemotherapy patients with extensive disease small cell lung cancer: final results of a randomized phase III trial显示文摘Eckardt JR yon Pawel J Manikhas G 2003Chemotherapy2003,49,4:1
2A phase Ⅲ, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenie chemotherapy 显示文摘Aapro M S Grunberg S M Manikhas G M 2006Ann Oncol2006,17,9:1
3Comparable activiy with oral topotecan/cisplatin(TC)and IV etopceide/cisplalin(PE) as treatment for chemotherapy patients(pts)with extensive disease small cell lung cancer(ED-SCLC):Final results of a randomized phase Ⅲ trial显示文摘Eckardt JR yon Pawel J Manikhas G 2005Proc Am Soc Clin Oncol2005,24,:1
4A phase III, dou- ble-blind,randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy 显示文摘Aapro M Grunberg S Manikhas G 2006Ann Oncol2006,17,19:1
5Comparable activily with oral topotecan/cisplatin (TC) and IV etoposide/cisplatin( PE ) as treatment for chemotherapy-na? ve patients with extensive disease small cell lung cancer: final results of a randomized phase Ⅲ trial显示文摘Eckardt JR yon Pawel J Manikhas G el al 2005Proc Am Soc Clin Oncol2005,,:1
6A phase Ⅲ, double blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly ernetogenic chemotherapy显示文摘Aapro M S Grunberg S M Manikhas G M etal 2006Ann Oncol2006,17,9:1
7A phase Ⅲ , double blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy 显示文摘Aapro M S Grunberg S M Manikhas G M 2006Ann Oncol2006,17,9:1
8Companable activity with oral topotecan/cisplatin(TC) and Ⅳ etoposide/cisplatin(PE) as treatment of chemotherapy naive patients (pts)with extensive disease small cell lung cancer (ED-SCLC):Final results of a randomized phase Ⅲ trial(389)显示文摘PAWEL J MANIKHAS G PAPAI Z 2005J Clin Oncol2005,126,10:1
9A phase III,doubleblind,randomized trial of palonosetron compared with ondansetron in preventing chemotherapyinduced nausea and vomiting following highly emetogenic chemotherapy显示文摘AAPRO1 M S GRUNBERG S M MANIKHAS G M 2006Ann Oncol2006,17,9:1
10A phase III,double -blind,randomized trial of palonosetron compared withondansetron in preventing chemotherapy -induced nausea andvomiting following highly emetogenic chemotherapy 显示文摘Aapro M S Grunberg S M Manikhas G M 2006Ann Oncol2006,17,9:1
11Phase Ⅱ genomics study in patients receiving ixabepilone as neoadjuvant treatment for breast cancer (BC) : preliminary efficacy and safety data显示文摘Cussac AL Baselga J Manikhas G 2005J Clin Oncol2005,23,16:1
12Comparable activity with oral topotecan/cisplatin (TC) and Ⅳ etoposide/cisplatin (PE) as treatment for chemotherapy-naive patients with extensive disease small cell lung cancer (ED-SCLC):Final results of a randomized phase Ⅲ trial显示文摘Eckardt JR Von-Pawel J Manikhas G 2005Proc Am Soc Clin Oncol2005,7003,:1
13Abraxane,a novel Cremophor-free,albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer显示文摘GREEN M R MANIKHAS G M ORLOV S 2006Ann Oncol2006,17,8:1
14A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy显示文摘AAPRO M S GRUNBERG S M MANIKHAS G M 2006Ann Oncol2006,17,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费